Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 229

1.

Diagnostic DNA Methylation Biomarkers for Renal Cell Carcinoma: A Systematic Review.

Lommen K, Vaes N, Aarts MJ, van Roermund JG, Schouten LJ, Oosterwijk E, Melotte V, Tjan-Heijnen VC, van Engeland M, Smits KM.

Eur Urol Oncol. 2019 Aug 9. pii: S2588-9311(19)30114-2. doi: 10.1016/j.euo.2019.07.011. [Epub ahead of print] Review.

2.

Molecular Profiling of Druggable Targets in Clear Cell Renal Cell Carcinoma Through Targeted RNA Sequencing.

van den Heuvel CNAM, van Ewijk A, Zeelen C, de Bitter T, Huynen M, Mulders P, Oosterwijk E, Leenders WPJ.

Front Oncol. 2019 Mar 1;9:117. doi: 10.3389/fonc.2019.00117. eCollection 2019.

3.

Reconstruction Strategies of the Ureter and Urinary Diversion Using Tissue Engineering Approaches.

Janke HP, de Jonge PKJD, Feitz WFJ, Oosterwijk E.

Tissue Eng Part B Rev. 2019 Jun;25(3):237-248. doi: 10.1089/ten.TEB.2018.0345. Epub 2019 May 28.

PMID:
30794111
4.

Synthetic Extracellular Matrices with Nonlinear Elasticity Regulate Cellular Organization.

Liu K, Mihaila SM, Rowan A, Oosterwijk E, Kouwer PHJ.

Biomacromolecules. 2019 Feb 11;20(2):826-834. doi: 10.1021/acs.biomac.8b01445. Epub 2019 Jan 22.

5.

Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma.

Nagao K, Shinohara N, Smit F, de Weijert M, Jannink S, Owada Y, Mulders P, Oosterwijk E, Matsuyama H.

BMC Cancer. 2018 Nov 15;18(1):1114. doi: 10.1186/s12885-018-5060-8.

6.

Inducing intravesical hyperthermia of the ex-vivo porcine bladder wall: radiofrequency-induction versus recirculation using a custom-made device.

van Valenberg FJP, Witjes JA, Aklan B, de Jong SF, Zegers H, Oosterwijk E.

Int J Hyperthermia. 2018;35(1):323-329. doi: 10.1080/02656736.2018.1499046. Epub 2018 Oct 10.

PMID:
30303406
7.

Aortic allografts: final destination?-a summary of clinical tracheal substitutes.

Siddiqi S, de Wit R, van der Heide S, Oosterwijk E, Verhagen A.

J Thorac Dis. 2018 Aug;10(8):5149-5153. doi: 10.21037/jtd.2018.07.108. Review.

8.

The Impact of γ-Irradiation and EtO Degassing on Tissue Remodeling of Collagen-based Hybrid Tubular Templates.

Sloff M, Janke HP, de Jonge PKJD, Tiemessen DM, Kortmann BBM, Mihaila SM, Geutjes PJ, Feitz WFJ, Oosterwijk E.

ACS Biomater Sci Eng. 2018 Sep 10;4(9):3282-3290. doi: 10.1021/acsbiomaterials.8b00369. Epub 2018 Jul 25.

9.

Labeling of Collagen Type I Templates with a Naturally Derived Contrast Agent for Noninvasive MR Imaging in Soft Tissue Engineering.

Janke HP, Güvener N, Dou W, Tiemessen DM, YantiSetiasti A, Cremers JGO, Borm PJA, Feitz WFJ, Heerschap A, Kiessling F, Oosterwijk E.

Adv Healthc Mater. 2018 Sep;7(18):e1800605. doi: 10.1002/adhm.201800605. Epub 2018 Jul 29.

PMID:
30058274
10.

Assessment of the efficacy of repeated instillations of mitomycin C mixed with a thermosensitive hydrogel in an orthotopic rat bladder cancer model.

van Valenberg FJP, Strauss-Ayali D, Agmon-Gerstein Y, Friedman A, Arentsen HC, Schaafsma HE, Witjes JA, Oosterwijk E.

Ther Adv Urol. 2018 Mar 19;10(7):213-221. doi: 10.1177/1756287218762064. eCollection 2018 Jul.

11.

Curcumin as Treatment for Bladder Cancer: A Preclinical Study of Cyclodextrin-Curcumin Complex and BCG as Intravesical Treatment in an Orthotopic Bladder Cancer Rat Model.

Falke J, Parkkinen J, Vaahtera L, Hulsbergen-van de Kaa CA, Oosterwijk E, Witjes JA.

Biomed Res Int. 2018 Jun 10;2018:9634902. doi: 10.1155/2018/9634902. eCollection 2018.

12.

A placebo-controlled efficacy study of the intravesical immunomodulators TMX-101 and TMX-202 in an orthotopic bladder cancer rat model.

Falke J, Hulsbergen-van de Kaa CA, Maj R, Oosterwijk E, Witjes JA.

World J Urol. 2018 Nov;36(11):1719-1725. doi: 10.1007/s00345-018-2334-3. Epub 2018 May 16.

13.

Positron Emission Tomography/Computed Tomography with 89Zr-girentuximab Can Aid in Diagnostic Dilemmas of Clear Cell Renal Cell Carcinoma Suspicion.

Hekman MCH, Rijpkema M, Aarntzen EH, Mulder SF, Langenhuijsen JF, Oosterwijk E, Boerman OC, Oyen WJG, Mulders PFA.

Eur Urol. 2018 Sep;74(3):257-260. doi: 10.1016/j.eururo.2018.04.026. Epub 2018 May 3.

PMID:
29730017
14.

Tumor-targeted Dual-modality Imaging to Improve Intraoperative Visualization of Clear Cell Renal Cell Carcinoma: A First in Man Study.

Hekman MC, Rijpkema M, Muselaers CH, Oosterwijk E, Hulsbergen-Van de Kaa CA, Boerman OC, Oyen WJ, Langenhuijsen JF, Mulders PF.

Theranostics. 2018 Mar 8;8(8):2161-2170. doi: 10.7150/thno.23335. eCollection 2018.

15.

Pharmacokinetics and pharmacodynamics of intravesical and intravenous TMX-101 and TMX-202 in a F344 rat model.

Falke J, Hulsbergen-van de Kaa CA, Maj R, Oosterwijk E, Witjes JA.

Urol Oncol. 2018 May;36(5):242.e1-242.e7. doi: 10.1016/j.urolonc.2018.01.016. Epub 2018 Mar 2.

PMID:
29500135
16.

A Genetic Polymorphism in CTLA-4 Is Associated with Overall Survival in Sunitinib-Treated Patients with Clear Cell Metastatic Renal Cell Carcinoma.

Liu X, Swen JJ, Diekstra MHM, Boven E, Castellano D, Gelderblom H, Mathijssen RHJ, Vermeulen SH, Oosterwijk E, Junker K, Roessler M, Alexiusdottir K, Sverrisdottir A, Radu MT, Ambert V, Eisen T, Warren A, Rodríguez-Antona C, García-Donas J, Böhringer S, Koudijs KKM, Kiemeney LALM, Rini BI, Guchelaar HJ.

Clin Cancer Res. 2018 May 15;24(10):2350-2356. doi: 10.1158/1078-0432.CCR-17-2815. Epub 2018 Feb 28.

17.

Intravesical radiofrequency induced hyperthermia enhances mitomycin C accumulation in tumour tissue.

van Valenberg FJP, van der Heijden AG, Lammers RJM, Falke J, Arends TJH, Oosterwijk E, Witjes JA.

Int J Hyperthermia. 2018 Nov;34(7):988-993. doi: 10.1080/02656736.2017.1406618. Epub 2017 Dec 1.

PMID:
29191126
18.

Ureteral Reconstruction in Goats Using Tissue-Engineered Templates and Subcutaneous Preimplantation.

de Jonge PKJD, Sloff M, Janke HP, Versteegden LRM, Kortmann BBM, de Gier RPE, Geutjes PJ, Oosterwijk E, Feitz WFJ.

Tissue Eng Part A. 2018 Jun;24(11-12):863-872. doi: 10.1089/ten.TEA.2017.0347. Epub 2017 Dec 22.

PMID:
29105596
19.

GATA transcription factors in testicular adrenal rest tumours.

Engels M, Span PN, Mitchell RT, Heuvel JJTM, Marijnissen-van Zanten MA, van Herwaarden AE, Hulsbergen-van de Kaa CA, Oosterwijk E, Stikkelbroeck NM, Smith LB, Sweep FCGJ, Claahsen-van der Grinten HL.

Endocr Connect. 2017 Nov;6(8):866-875. doi: 10.1530/EC-17-0215. Epub 2017 Oct 16.

20.

Clinical protocol levels are required in laboratory animal surgery when using medical devices: experiences with ureteral replacement surgery in goats.

de Jonge PKJD, Sloff M, Janke HP, Kortmann BBM, de Gier RPE, Geutjes PJ, Oosterwijk E, Feitz WFJ.

Lab Anim. 2017 Oct;51(5):538-541. doi: 10.1177/0023677217696520. Epub 2017 Mar 16.

21.

Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.

de Groot S, Redekop WK, Versteegh MM, Sleijfer S, Oosterwijk E, Kiemeney LALM, Uyl-de Groot CA.

Qual Life Res. 2018 Jan;27(1):115-124. doi: 10.1007/s11136-017-1704-4. Epub 2017 Sep 15.

22.

Profiling of the metabolic transcriptome via single molecule molecular inversion probes.

de Bitter T, van de Water C, van den Heuvel C, Zeelen C, Eijkelenboom A, Tops B, Oosterwijk E, Kolev D, Mulders P, Ter Laan M, van Lith S, Leenders W.

Sci Rep. 2017 Sep 12;7(1):11402. doi: 10.1038/s41598-017-11035-0.

23.

A theranostic dental pulp capping agent with improved MRI and CT contrast and biological properties.

Mastrogiacomo S, Güvener N, Dou W, Alghamdi HS, Camargo WA, Cremers JGO, Borm PJA, Heerschap A, Oosterwijk E, Jansen JA, Walboomers XF.

Acta Biomater. 2017 Oct 15;62:340-351. doi: 10.1016/j.actbio.2017.08.018. Epub 2017 Aug 24.

PMID:
28842333
24.

Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging.

Hekman MCH, Boerman OC, Bos DL, Massuger LFAG, Weil S, Grasso L, Rybinski KA, Oosterwijk E, Mulders PFA, Rijpkema M.

Mol Pharm. 2017 Oct 2;14(10):3457-3463. doi: 10.1021/acs.molpharmaceut.7b00464. Epub 2017 Aug 30.

25.

Preclinical validation of 111In-girentuximab-F(ab')2 as a tracer to image hypoxia related marker CAIX expression in head and neck cancer xenografts.

Huizing FJ, Hoeben BAW, Franssen G, Lok J, Heskamp S, Oosterwijk E, Boerman OC, Bussink J.

Radiother Oncol. 2017 Sep;124(3):521-525. doi: 10.1016/j.radonc.2017.07.025. Epub 2017 Aug 5.

PMID:
28789809
26.

Intraoperative Imaging Techniques to Support Complete Tumor Resection in Partial Nephrectomy.

Hekman MCH, Rijpkema M, Langenhuijsen JF, Boerman OC, Oosterwijk E, Mulders PFA.

Eur Urol Focus. 2018 Dec;4(6):960-968. doi: 10.1016/j.euf.2017.04.008. Epub 2017 May 12. Review.

PMID:
28753888
27.

Bioinspired coupled helical coils for soft tissue engineering of tubular structures - Improved mechanical behavior of tubular collagen type I templates.

Janke HP, Bohlin J, Lomme RMLM, Mihaila SM, Hilborn J, Feitz WFJ, Oosterwijk E.

Acta Biomater. 2017 Sep 1;59:234-242. doi: 10.1016/j.actbio.2017.06.038. Epub 2017 Jun 27.

PMID:
28666884
28.

Population Modeling Integrating Pharmacokinetics, Pharmacodynamics, Pharmacogenetics, and Clinical Outcome in Patients With Sunitinib-Treated Cancer.

Diekstra MH, Fritsch A, Kanefendt F, Swen JJ, Moes D, Sörgel F, Kinzig M, Stelzer C, Schindele D, Gauler T, Hauser S, Houtsma D, Roessler M, Moritz B, Mross K, Bergmann L, Oosterwijk E, Kiemeney LA, Guchelaar HJ, Jaehde U.

CPT Pharmacometrics Syst Pharmacol. 2017 Sep;6(9):604-613. doi: 10.1002/psp4.12210. Epub 2017 Jul 13.

29.

Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments.

De Groot S, Blommestein HM, Redekop WK, Sleijfer S, Kiemeney LALM, Oosterwijk E, Uyl-de Groot CA.

PLoS One. 2017 May 22;12(5):e0177364. doi: 10.1371/journal.pone.0177364. eCollection 2017.

30.

Description of the EuroTARGET cohort: A European collaborative project on TArgeted therapy in renal cell cancer-GEnetic- and tumor-related biomarkers for response and toxicity.

van der Zanden LFM, Vermeulen SH, Oskarsdottir A, Maurits JSF, Diekstra MHM, Ambert V, Cambon-Thomsen A, Castellano D, Fritsch A, Garcia Donas J, Guarch Troyas R, Guchelaar HJ, Hartmann A, Hulsbergen-van de Kaa C, Jaehde U, Junker K, Martinez-Cardus A, Masson G, Oosterwijk-Wakka J, Radu MT, Rafnar T, Rodriguez-Antona C, Roessler M, Ruijtenbeek R, Stefansson K, Warren A, Wessels L, Eisen T, Kiemeney LALM, Oosterwijk E.

Urol Oncol. 2017 Aug;35(8):529.e9-529.e16. doi: 10.1016/j.urolonc.2017.03.009. Epub 2017 Apr 3.

31.

Tissue Engineering of the Urethra: A Systematic Review and Meta-analysis of Preclinical and Clinical Studies.

Versteegden LRM, de Jonge PKJD, IntHout J, van Kuppevelt TH, Oosterwijk E, Feitz WFJ, de Vries RBM, Daamen WF.

Eur Urol. 2017 Oct;72(4):594-606. doi: 10.1016/j.eururo.2017.03.026. Epub 2017 Apr 4. Review.

PMID:
28385451
32.

Bladder Regeneration Using Multiple Acellular Scaffolds with Growth Factors in a Bladder.

Roelofs LAJ, de Jonge PKJD, Oosterwijk E, Tiemessen DM, Kortmann BBM, de Gier RPE, Versteeg EMM, Daamen WF, van Kuppevelt TH, Geutjes PJ, Feitz WFJ.

Tissue Eng Part A. 2018 Jan;24(1-2):11-20. doi: 10.1089/ten.TEA.2016.0356. Epub 2017 May 2.

PMID:
28322621
33.

The effect of a cyclic uniaxial strain on urinary bladder cells.

Tiemessen D, de Jonge P, Daamen W, Feitz W, Geutjes P, Oosterwijk E.

World J Urol. 2017 Oct;35(10):1531-1539. doi: 10.1007/s00345-017-2013-9. Epub 2017 Feb 23.

34.

Tubular collagen scaffolds with radial elasticity for hollow organ regeneration.

Versteegden LR, van Kampen KA, Janke HP, Tiemessen DM, Hoogenkamp HR, Hafmans TG, Roozen EA, Lomme RM, van Goor H, Oosterwijk E, Feitz WF, van Kuppevelt TH, Daamen WF.

Acta Biomater. 2017 Apr 1;52:1-8. doi: 10.1016/j.actbio.2017.02.005. Epub 2017 Feb 5.

PMID:
28179160
35.

Detection of Micrometastases Using SPECT/Fluorescence Dual-Modality Imaging in a CEA-Expressing Tumor Model.

Hekman MCH, Rijpkema M, Bos DL, Oosterwijk E, Goldenberg DM, Mulders PFA, Boerman OC.

J Nucl Med. 2017 May;58(5):706-710. doi: 10.2967/jnumed.116.185470. Epub 2017 Jan 26.

36.

Ureteral reconstruction with reinforced collagen scaffolds in a porcine model.

de Jonge P, Simaioforidis V, Geutjes P, Oosterwijk E, Feitz W.

J Tissue Eng Regen Med. 2018 Jan;12(1):80-88. doi: 10.1002/term.2366. Epub 2017 Jun 7. No abstract available.

PMID:
27860431
37.

Design of an elasticized collagen scaffold: A method to induce elasticity in a rigid protein.

Versteegden LR, Hoogenkamp HR, Lomme RM, van Goor H, Tiemessen DM, Geutjes PJ, Oosterwijk E, Feitz WF, Hafmans TG, Verdonschot N, Daamen WF, van Kuppevelt TH.

Acta Biomater. 2016 Oct 15;44:277-85. doi: 10.1016/j.actbio.2016.08.038. Epub 2016 Aug 21.

PMID:
27554020
38.

Scaffolds for whole organ tissue engineering: Construction and in vitro evaluation of a seamless, spherical and hollow collagen bladder construct with appendices.

Hoogenkamp HR, Pot MW, Hafmans TG, Tiemessen DM, Sun Y, Oosterwijk E, Feitz WF, Daamen WF, van Kuppevelt TH.

Acta Biomater. 2016 Oct 1;43:112-121. doi: 10.1016/j.actbio.2016.07.022. Epub 2016 Jul 14.

PMID:
27424084
39.

A five-gene expression signature to predict progression in T1G3 bladder cancer.

van der Heijden AG, Mengual L, Lozano JJ, Ingelmo-Torres M, Ribal MJ, Fernández PL, Oosterwijk E, Schalken JA, Alcaraz A, Witjes JA.

Eur J Cancer. 2016 Sep;64:127-36. doi: 10.1016/j.ejca.2016.06.003. Epub 2016 Jul 11.

PMID:
27414486
40.

Functional Analysis of Vascularized Collagen/Fibrin Templates by MRI In Vivo.

Sun W, Sun Y, Klar AS, Geutjes P, Reichmann E, Heerschap A, Oosterwijk E.

Tissue Eng Part C Methods. 2016 Aug;22(8):747-55. doi: 10.1089/ten.TEC.2016.0035. Epub 2016 Jul 14.

PMID:
27324220
41.

Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry.

De Groot S, Sleijfer S, Redekop WK, Oosterwijk E, Haanen JB, Kiemeney LA, Uyl-de Groot CA.

BMC Cancer. 2016 Jun 11;16:364. doi: 10.1186/s12885-016-2395-x.

42.

Tubular Constructs as Artificial Urinary Conduits.

Sloff M, Simaioforidis V, Tiemessen DM, Janke HP, Kortmann BB, Roelofs LA, Geutjes PJ, Oosterwijk E, Feitz WF.

J Urol. 2016 Oct;196(4):1279-86. doi: 10.1016/j.juro.2016.04.092. Epub 2016 May 13.

PMID:
27185613
43.

Survival in Patients With Primary Metastatic Renal Cell Carcinoma Treated With Sunitinib With or Without Previous Cytoreductive Nephrectomy: Results From a Population-based Registry.

de Groot S, Redekop WK, Sleijfer S, Oosterwijk E, Bex A, Kiemeney LA, Uyl-de Groot CA.

Urology. 2016 Sep;95:121-7. doi: 10.1016/j.urology.2016.04.042. Epub 2016 May 11.

PMID:
27179773
44.

Targeted Dual-Modality Imaging in Renal Cell Carcinoma: An Ex Vivo Kidney Perfusion Study.

Hekman MC, Boerman OC, de Weijert M, Bos DL, Oosterwijk E, Langenhuijsen JF, Mulders PF, Rijpkema M.

Clin Cancer Res. 2016 Sep 15;22(18):4634-42. doi: 10.1158/1078-0432.CCR-15-2937. Epub 2016 Apr 21.

45.

Novel tubular constructs for urinary diversion: a biocompatibility study in pigs.

Sloff M, Simaioforidis V, Geutjes PJ, Hoogenkamp HR, van Kuppevelt TH, Daamen WF, Oosterwijk E, Feitz WF.

J Tissue Eng Regen Med. 2017 Aug;11(8):2241-2249. doi: 10.1002/term.2122. Epub 2016 Feb 16.

PMID:
26880718
46.

Phase 2 Study of Lutetium 177-Labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma.

Muselaers CH, Boers-Sonderen MJ, van Oostenbrugge TJ, Boerman OC, Desar IM, Stillebroer AB, Mulder SF, van Herpen CM, Langenhuijsen JF, Oosterwijk E, Oyen WJ, Mulders PF.

Eur Urol. 2016 May;69(5):767-70. doi: 10.1016/j.eururo.2015.11.033. Epub 2015 Dec 23.

PMID:
26706103
47.

Bladder Regeneration Using a Smart Acellular Collagen Scaffold with Growth Factors VEGF, FGF2 and HB-EGF.

Roelofs LA, Oosterwijk E, Kortmann BB, Daamen WF, Tiemessen DM, Brouwer KM, Eggink AJ, Crevels AJ, Wijnen RM, van Kuppevelt TH, Geutjes PJ, Feitz WF.

Tissue Eng Part A. 2016 Jan;22(1-2):83-92. doi: 10.1089/ten.TEA.2015.0096. Epub 2015 Dec 1.

PMID:
26441140
48.

Biodistribution of size-selected lyophilisomes in mice.

van Bracht E, Raavé R, Perevyazko IY, Versteeg EM, Hafmans TG, Schubert US, Oosterwijk E, van Kuppevelt TH, Daamen WF.

Eur J Pharm Biopharm. 2015 Aug;94:141-51. doi: 10.1016/j.ejpb.2015.04.020. Epub 2015 May 5.

PMID:
25953331
49.

Successful combination of sunitinib and girentuximab in two renal cell carcinoma animal models: a rationale for combination treatment of patients with advanced RCC.

Oosterwijk-Wakka JC, de Weijert MC, Franssen GM, Leenders WP, van der Laak JA, Boerman OC, Mulders PF, Oosterwijk E.

Neoplasia. 2015 Feb;17(2):215-24. doi: 10.1016/j.neo.2014.12.011.

50.

Radionuclide and Fluorescence Imaging of Clear Cell Renal Cell Carcinoma Using Dual Labeled Anti-Carbonic Anhydrase IX Antibody G250.

Muselaers CH, Rijpkema M, Bos DL, Langenhuijsen JF, Oyen WJ, Mulders PF, Oosterwijk E, Boerman OC.

J Urol. 2015 Aug;194(2):532-8. doi: 10.1016/j.juro.2015.02.041. Epub 2015 Feb 14.

PMID:
25686542

Supplemental Content

Loading ...
Support Center